Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Heron Therapeutics, Inc.
*MAILING ADDRESS
4242 Campus Point Court, Suite 200
*CITY
San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations
for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea
treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects;
pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases,
infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Beth M. Goldman
ATTORNEY DOCKET NUMBER
21539-6000
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Orrick, Herrington & Sutcliffe LLP
INTERNAL ADDRESS
IP Prosecution Department
STREET
2050 Main Street, Suite 1100
CITY
Irvine
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
92614-8255
PHONE
415-773-5700
FAX
949-567-6710
EMAIL ADDRESS
ipprosecutionsf@orrick.com
OTHER APPOINTED ATTORNEY
Betsy Wang Lee, Ashlie J. Smith, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr.
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97038308
Filing Date:09/21/2021
To the Commissioner for Trademarks:
MARK: APONVIE (Standard Characters, see mark)
The literal element of the mark consists of APONVIE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Heron Therapeutics, Inc., a corporation of Delaware, having an address of
4242 Campus Point Court, Suite 200
San Diego, California 92121
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of
post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations;
pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical
preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious
diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Beth M. Goldman. Other appointed attorneys are Betsy Wang Lee, Ashlie J. Smith, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M.
Wright, Robert M. O'Connell Jr.. Beth M. Goldman of Orrick, Herrington & Sutcliffe LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is
located at
IP Prosecution Department
2050 Main Street, Suite 1100
Irvine, California 92614-8255
United States
415-773-5700(phone)
949-567-6710(fax)
ipprosecutionsf@orrick.com
The docket/reference number is 21539-6000.
Beth M. Goldman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Thomas Ottoboni/ Date: 09/21/2021
Signatory's Name: Thomas Ottoboni
Signatory's Position: Senior VP
Signatory's Phone Number: 415-773-5700
Signature method: Sent to third party for signature
Payment Sale Number: 97038308
Payment Accounting Date: 09/21/2021
Serial Number: 97038308
Internet Transmission Date: Tue Sep 21 18:21:45 ET 2021
TEAS Stamp: USPTO/BAS-X.XX.XXX.X-2021092118214558677
3-97038308-781443ea5efa647d95d15abf812b7
6d743e31c700ede3c08a893b66da9f3de0c2-DA-
21453841-20210921170706652992